webinar register page

Webinar banner
Wildtype & Hereditary Transthyretin Amyloidosis
Program

Opening remarks and speakers introduction (5 minutes)
Chair: PD Dr. Marie Théaudin, Head of Neuromuscular Diseases Unit at CHUV

hATTR amyloidosis: disease from a neurological perspective (10 minutes) + Q&A (10 minutes)
PD Dr. Marie Théaudin, Lead Physician Neurology at CHUV

Disease from a cardiac perspective (10 minutes) + Q&A (10 minutes)
PD Dr. Andreas Flammer, Head of heart failure/transplantation Unit at USZ

RNA interference technology – from Noble Prize to clinical practice (10 minutes) + Q&A (10 minutes)
Klaus Charisse, Ph.D., Senior Director RNAi Discovery at Alnylam Pharmaceuticals

Patient case and therapy options (10 minutes) + Q&A (10 minutes)
Dr. Rahel Schwotzer, Lead Physician meV Hematology at USZ

Echo demonstration and discussion of an ATTR patient (10 minutes) + Q&A (10 minutes)
Dr. Simon Stämpfli, Head of Outpatient Clinic and Echocardiography at LUKS

Closing remarks (5 minutes)
PD Dr. Marie Théaudin, Head of Neuromuscular Diseases Unit at CHUV

Dec 2, 2020 04:00 PM in Zurich

* Required information
Loading

By registering, I agree to the Privacy Statement and Terms of Service.

Register